Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Drug Safety
FDA Mulls Diabetes Drug Disclosure
March 31st, 2000
The U.S. Food and Drug Administration is studying a request that it investigate a major drug manufacturer for delaying submission of information that a diabetes drug could cause liver problems in some patients. The public interest group Public Citizen called for the probe into Warner-Lambert/Parke-Davis, charging the company knew of instances of liver problems associated with the drug Rezulin before it went on the market, but delayed informing the FDA. An FDA spokesman, speaking on condition of anonymity to the Associated Press, said the agency is reviewing the request for an investigation and will take whatever action is appropriate. ...
Source: Drug Week (2000-03-31)
|
